Page last updated: 2024-11-08

chloramphenicol and Budd-Chiari Syndrome

chloramphenicol has been researched along with Budd-Chiari Syndrome in 1 studies

Amphenicol: Chloramphenicol and its derivatives.

Budd-Chiari Syndrome: A condition in which the hepatic venous outflow is obstructed anywhere from the small HEPATIC VEINS to the junction of the INFERIOR VENA CAVA and the RIGHT ATRIUM. Usually the blockage is extrahepatic and caused by blood clots (THROMBUS) or fibrous webs. Parenchymal FIBROSIS is uncommon.

Research Excerpts

ExcerptRelevanceReference
" The half-life of chloramphenicol (t 1/2) was increased in the various liver disorders, the metabolic clearance rate (MCR) and apparent volume of distribution (Vd) were decreased and the area under the time - concentrations curve (AUC) showed an increase."1.26Pharmacokinetic study of chloramphenicol in patients with liver disease. ( Datta, DV; Mathur, VS; Narang, AP; Nath, N, 1981)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Narang, AP1
Datta, DV1
Nath, N1
Mathur, VS1

Other Studies

1 other study available for chloramphenicol and Budd-Chiari Syndrome

ArticleYear
Pharmacokinetic study of chloramphenicol in patients with liver disease.
    European journal of clinical pharmacology, 1981, Volume: 20, Issue:6

    Topics: Acute Disease; Adult; Budd-Chiari Syndrome; Chloramphenicol; Female; Half-Life; Hepatitis; Humans; H

1981